IL227921A0 - Methods of prognosing and administering treatment for inflammatory disorders - Google Patents

Methods of prognosing and administering treatment for inflammatory disorders

Info

Publication number
IL227921A0
IL227921A0 IL227921A IL22792113A IL227921A0 IL 227921 A0 IL227921 A0 IL 227921A0 IL 227921 A IL227921 A IL 227921A IL 22792113 A IL22792113 A IL 22792113A IL 227921 A0 IL227921 A0 IL 227921A0
Authority
IL
Israel
Prior art keywords
prognosing
methods
inflammatory disorders
administering treatment
administering
Prior art date
Application number
IL227921A
Other languages
Hebrew (he)
Original Assignee
Genqual Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/024448 external-priority patent/WO2012109427A1/en
Application filed by Genqual Corp filed Critical Genqual Corp
Publication of IL227921A0 publication Critical patent/IL227921A0/en

Links

IL227921A 2011-02-10 2013-08-11 Methods of prognosing and administering treatment for inflammatory disorders IL227921A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44151611A 2011-02-10 2011-02-10
PCT/US2012/024448 WO2012109427A1 (en) 2011-02-10 2012-02-09 Methods of prognosing and administering treatment for inflammatory disorders

Publications (1)

Publication Number Publication Date
IL227921A0 true IL227921A0 (en) 2013-09-30

Family

ID=49328890

Family Applications (1)

Application Number Title Priority Date Filing Date
IL227921A IL227921A0 (en) 2011-02-10 2013-08-11 Methods of prognosing and administering treatment for inflammatory disorders

Country Status (1)

Country Link
IL (1) IL227921A0 (en)

Similar Documents

Publication Publication Date Title
IL274469A (en) Compositions, uses and methods for treatment of metabolic disorders and diseases
HK1214832A1 (en) Compositions and methods for treatment of metabolic disorders and diseases
IL226401A0 (en) Methods of treating fgf21-associated disorders
EP2670434A4 (en) Treatment of tauopathies
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
EP2717855A4 (en) Methods of treatment
HK1199015A1 (en) Treatment of inflammation
EP2723347A4 (en) Prevention and treatment of inflammatory conditions
EP2763540A4 (en) Compositions and methods for assessing and treating inflammatory diseases and disorders
EP2696874A4 (en) Compositions and methods for the treatment of nasal conditions
HK1199261A1 (en) Methods for treatment of diseases
EP2544703A4 (en) Methods of treating vascular inflammatory disorders
GB201202773D0 (en) Compositions for treatment of skin disorders
HK1204573A1 (en) Treatment of inflammatory skin disorders
IL225896A0 (en) Treatment of mecp2-associated disorders
EP2788012A4 (en) Compositions and methods for treatment of kidney diseases
GB2496688B (en) Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
EP2741771A4 (en) Methods and compositions for the treatment of autoimmune and inflammatory diseases
EP2675275A4 (en) Compositions and methods for the treatment of obesity and related disorders
EP2670243A4 (en) Compositions and methods for treatment of glaucoma
EP2681209A4 (en) Compounds and methods for the treatment of pain and other disorders
EP2673372A4 (en) Methods of prognosing and administering treatment for inflammatory disorders
IL223385B (en) Treatment of inflammatory disorders
EP2600716A4 (en) Methods and compositions for treatment of metabolic disorders
IL227921A0 (en) Methods of prognosing and administering treatment for inflammatory disorders